Creating the future through the R&D of next-generation optical Earth observation satellites and advanced medical devices.

Overview

Founded on Earth Day, April 22, 2020, our vision is to "sustain a society that can look to the future with hope through technological innovation." Driven by our proprietary high-speed signal processing sensing technology, we actively support R&D for research institutions and private companies. Concurrently, we are developing and commercializing next-generation optical Earth observation satellite constellations, while adapting this cutting-edge technology for healthcare and medical devices.

Development, production, and sales of companion diagnostics

Overview

More than 300 kinds of development of a FISH probe, production and sale are being performed from 200,000 kinds of BAC clone built originally.
The product in which the cancer relation, genetic abnormal of diagnosis preimplantation and regenerative medicine (iPS cell) are detected has been often developed.
These products are also used by foreign countries, not only the country and appear on a paper beyond 120 reports.

Sales of reagents, clinical test drugs, industrial medicine, and equipment for clinical trials and chemistry use

Conducting a consulting business in the field of medicine

Development of endoscopic cancer treatment equipment using laser

R&D of medical mini-robot including self-propelling capsule endoscopy

Overview

MU Ltd. was founded in 2011 to realize the self-propelling capsule endoscopy nicknamed “MiniMermaid” with individual and continued 20 years development at an university.
The system will be a pioneer of painless medical mini-robot capable of moving freely in a body and conducting medical treatment of digestive tract.
Applying “MiniMermaid” technology, we have developed an aquatic mini drone to swim freely in 3-D space under water.

R&D, production and sale of biochips

Overview

The biochip technology of MYTEC can detect the substance of a very very small quantity molecular level in a short time. It was the first in the world to success is effective to adsorb specifically protein biochip surface "quantum crystal," "peroxide meso silver crystal" (3-dimensional self-assembled crystal) produced.
Simple, rapid, epigenetic analysis Proteo ® chip is the "new biochip".

Production and sales of radioactive pharmaceuticals

Overview

Nihon Medi-Physics Co., Ltd. is in a leading position in the manufacture and distribution of radiopharmaceuticals, which play an important role for diagnosis of cerebral vascular disorder, dementia, heart disease and cancer. Recognizing our mission as seeking novel value to nuclear medicine through our effort to develop new product and technology, we provide contracted services of labeling existing or new drug candidate substances with radioisotopes. Through such services, we support non-clinical/clinical studies of pharmaceutical companies in patients screening and in evaluating clinical outcome of new drug candidates. We aim at materializing “Theranostics (therapeutics and diagnostics combined)” by nuclear medicine and determine to continue contribution to further advancement of medical care.